PRAGUE, Czech Republic — A 0.4-mg/kg bolus dose of tenecteplase (TNKase, Genentech) was associated with functional outcomes and safety similar to those seen with the standard of care, alteplase ...
BOSTON, Sept 24 (Reuters) - Doctors are given just three hours to administer the clot-busting drug alteplase to help stroke patients, but a study released on Wednesday shows the drug still does some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback